Kennedy's new vaccine advisers meet for first time
Dr. Martin Kulldorf speaks during a meeting of the Advisory Committee in Immunization Practices at the CDC, Wednesday, June 25, 2025, in Atlanta. (AP Photo/Mike Stewart)
By MIKE STOBBE and LAURAN NEERGAARD
U.S. Health Secretary Robert F. Kennedy Jr.'s new vaccine advisers began their first meeting Wednesday under intense scrutiny from medical experts worried about Americans' access to lifesaving shots.
First on the agenda is an awkward scenario: Kennedy already announced COVID-19 vaccines will no longer be recommended for healthy children or pregnant women, and his new advisers aren't scheduled to vote on whether they agree. Yet government scientists prepared meeting materials calling vaccination 'the best protection' during pregnancy — and said most children hospitalized for COVID-19 over the past year were unvaccinated.
COVID-19 remains a public health threat, resulting in 32,000 to 51,000 U.S. deaths and more than 250,000 hospitalizations since last fall, according to the Centers for Disease Control and Prevention. Most at risk for hospitalization are seniors and children under 2 — especially infants under 6 months who could have some protection if their mom got vaccinated during pregnancy, according to the CDC's presentation.
It's one signal that this week's two-day meeting of the Advisory Committee on Immunization Practices isn't business as usual.
Another sign: Shortly before the meeting, a Virginia-based obstetrician and gynecologist stepped down from the committee, bringing the panel's number to just seven. The Trump administration said Dr. Michael Ross withdrew during a customary review of members' financial holdings.
The meeting opened as the American Academy of Pediatrics announced that it will continue publishing its own vaccine schedule for children but now will do so independently of the ACIP, calling it 'no longer a credible process.'
The panel, created more than 60 years ago, helps the CDC determine who should be vaccinated against a long list of diseases, and when. Those recommendations have a big impact on whether insurance covers vaccinations and where they're available, such as at pharmacies.
Earlier this month, Kennedy abruptly dismissed the existing 17-member expert panel and handpicked eight replacements, including several anti-vaccine voices. And a number of the CDC's top vaccine scientists — including some who lead the reporting of data and the vetting of presentations at ACIP meetings — have resigned or been moved out of previous positions.
The highly unusual moves prompted a last-minute plea from a prominent Republican senator to delay this week's meeting. Sen. Bill Cassidy of Louisiana, a physician who chairs the chamber's health committee, said Monday that many of Kennedy's chosen panelists lack the required expertise and 'may even have a preconceived bias' against new vaccine technologies.
In a House hearing Tuesday, Kennedy defended his purge, saying the old panel had been 'a template for medical malpractice.'
Rep. Kim Schrier, a pediatrician and Democrat from Washington state, told Kennedy: 'I will lay all responsibility for every death from a vaccine-preventable illness at your feet.'
The two-day meeting's agenda on was abruptly changed last week.
Discussion of COVID-19 shots will open the session on Wednesday. Later in the day, the committee will take up RSV, with votes expected. On Thursday, the committee will vote on fall flu vaccinations and on the use of a preservative in certain flu shots.
RSV, or respiratory syncytial virus, is a common cause of cold-like symptoms that can be dangerous for infants.
In 2023, U.S. health officials began recommending two new measures to protect infants — a lab-made antibody for newborns and a vaccine for pregnant women — that experts say likely drove an improvement in infant mortality.
The committee will discuss another company's newly approved antibody shot, but the exact language for the vote was not released prior to the meeting.
'I think there may be a theme of soft-pedaling or withdrawing recommendations for healthy pregnant women and healthy children,' even though they are at risk from vaccine-preventable diseases, said Lawrence Gostin, a public health law expert at Georgetown University who co-authored a recent medical journal commentary criticizing the COVID-19 vaccination decision.
At its June meetings, the committee usually refreshes guidance for Americans 6 month and older to get a flu shot, and helps greenlight the annual fall vaccination campaign.
But given the recent changes to the committee and federal public health leadership, it's unclear how routine topics will be treated, said Jason Schwartz, a Yale University health policy researcher who has studied the committee.
Thursday also promises controversy. The advisory panel is set to consider a preservative in a subset of flu shots that Kennedy and some antivaccine groups have falsely contended is tied to autism. In preparation, the CDC posted a new report confirming that research shows no link between the preservative, thimerosal, and autism or any other neurodevelopmental disorders.
Gostin said the agenda appears to be 'a combination of what we would normally expect ACIP to cover along with a mixture of potential conspiracy theories,' he said. 'We clearly are in a new normal that's highly skeptical of vaccine science.'
The committee's recommendations traditionally go to the Centers for Disease Control and Prevention director. Historically, nearly all are accepted and then used by insurance companies in deciding what vaccines to cover.
But the CDC currently has no director, so the committee's recommendations have been going to Kennedy, and he has yet to act on a couple recommendations ACIP made in April.
The CDC director nominee, Susan Monarez, is slated to go before a Senate committee on Wednesday.
© Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Nikkei Asia
a day ago
- Nikkei Asia
Nissin launches nutritious meals in US as weight loss drugs take off
In the U.S., Kanzen Meal is starting out with three types of frozen meals. (Kanzen Meal (U.S.A.)) HIROKO NISHIMURA NEW YORK -- Nissin Foods Holdings is bringing its popular Kanzen Meshi brand to the U.S., seeking to tap into the growing demand for convenient, nutritious meals among Americans using weight loss drugs. Nissin announced Thursday the launch of three products in the frozen meal line, including spaghetti bolognese, in California under the Kanzen Meal name. The plan is to go national by 2027.
Yomiuri Shimbun
a day ago
- Yomiuri Shimbun
Startup Sells Plastic-eating Fungi Diapers to Tackle Landfill Waste
AUSTIN, Texas (Reuters) — Could baby poop and fungi work together to tackle landfill waste? That's the idea behind a new product launched by an Austin, Texas-based startup that sells disposable diapers paired with fungi intended to break down the plastic. Each of Hiro Technologies' MycoDigestible Diapers comes with a packet of fungi to be added to the dirty diaper before it is thrown in the trash. After a week or two, the fungi are activated by moisture from feces, urine and the environment to begin the process of biodegradation. Disposable diapers contribute significantly to landfill waste. An estimated 4 million tons of diapers were disposed of in the United States in 2018, with no significant recycling or composting, according to the Environmental Protection Agency. Diapers take hundreds of years to naturally break down. That means the very first disposable diaper ever used is still in a landfill somewhere. To tackle this, Hiro Technologies turned to fungi. These organisms — which include mushrooms, molds, yeasts and mildew — derive nutrients from decomposing organic matter. In 2011, Yale University researchers discovered a type of fungus in Ecuador that can feed on polyurethane, a common polymer in plastic products. They figured the fungus, Pestalotiopsis microspora, would be capable of surviving on plastic in environments lacking oxygen, like landfills. Hiro Technologies cofounder Tero Isokauppila, a Finnish entrepreneur who also founded medicinal mushroom company Four Sigmatic, said there are more than 100 species of fungi now known to break down plastics. 'Many, many moons ago, fungi evolved to break down trees, especially this hard-to-break-down compound in trees called lignin … Its carbon backbone is very similar to the carbon backbone of plastics because essentially they're made out of the same thing,' Isokauppila said. Three sealed jars at Hiro Technologies' lab show the stages of decomposition of a treated diaper over time. By nine months, the product appears as black soil — 'just digested plastic and essentially earth,' Isokauppila said. The company says it needs to do more research to find out how the product will decompose in real-world conditions in different climates and hopes to have the data to make a 'consumer-facing claim' by next year. It also plans to experiment with plastic-eating fungi on adult diapers, feminine care products and other now, it is selling 'diaper bundles' for $35 a week online. Cofounder Miki Agrawal, who was also behind period underwear company Thinx, said the MycoDigestible Diapers had been generating excitement from consumers and investors since launching about a month ago, declining to give details. Agrawal said the company had chosen to focus on diapers as the top household plastic waste item. 'There is a deleterious lasting effect that we haven't really thought about and considered,' Agrawal said. 'Because when you throw something away, no one's asking themselves, 'Where's away?''
Yomiuri Shimbun
a day ago
- Yomiuri Shimbun
Kennedy Says US Is Pulling Funding from Global Vaccine Group Gavi
LONDON (AP) — U.S. Health Secretary Robert F. Kennedy Jr. says the country is pulling its support from the vaccines alliance Gavi, saying the organization has 'ignored the science' and 'lost the public trust.' A video of Kennedy's short speech was shown to a Gavi meeting in Brussels on Wednesday, where the organization that has paid for more than 1 billion children to be vaccinated through routine immunization programs was hoping to raise at least $9 billion for the next five years. Kennedy, a longtime vaccine skeptic, mentioned Gavi's partnership with the World Health Organization during COVID-19, accusing them of silencing 'dissenting views' and 'legitimate questions' about vaccine safety. His speech also cast doubt on the diphtheria, tetanus and pertussis vaccine — which WHO and other health agencies have long deemed to be safe and effective. Gavi said in a statement Thursday that its 'utmost concern is the health and safety of children,' adding that any decision it makes on vaccines to buy is done in accordance with recommendations issued by WHO's expert vaccine group. Some doctors in the United States criticized the decision. Dr. Paul Offit, director of the Vaccine Center at the Children's Hospital of Philadelphia, said it was 'incredibly dangerous' and warned that defunding immunization would put millions of children at risk. Gavi is a public-private partnership including WHO, UNICEF, the Gates Foundation and the World Bank, and it is estimated that the vaccination programs have saved 18 million lives. The United States has long been one of its biggest supporters; before President Donald Trump's re-election, the country had pledged $1 billion through 2030. In just under four minutes, Kennedy called on Gavi 'to justify the $8 billion America has provided in funding since 2001,' saying officials must 'consider the best science available, even when that science contradicts established paradigms.' Kennedy said until that happens, the U.S. won't contribute further to Gavi. The health secretary zeroed in on the COVID-19 vaccine, which WHO, Gavi and other health authorities have recommended for pregnant women, saying they are at higher risk of severe disease. Kennedy called that a 'questionable' recommendation; his U.S. Centers for Disease Control and Prevention recently stopped recommending it. He also criticized Gavi for funding of a rollout a vaccine to prevent diphtheria, tetanus and pertussis in poorer countries, saying he'd seen research that concluded that young girls who got the vaccine were more likely to die from all other causes than children who weren't immunized. Gavi said scientists had reviewed all available data, including any studies that raised concerns, and that the diphtheria, tetanus and pertussis vaccine has 'played a key role in helping halve childhood mortality.' Some observational studies have shown that vaccinated girls do have a higher death rate compared to unvaccinated children, but there is no evidence the deaths are caused by the vaccine. But Offit said the studies cited by Kennedy were not convincing and that research examining links between vaccinations and deaths did not prove a causal connection. 'There's no mechanism here which makes biological sense for why the (diphtheria, tetanus and pertussis vaccine) might result in more children dying,' Offit said. Doctors Without Borders on Thursday predicted 'countless children will die from vaccine-preventable diseases' as a result of the U.S. withdrawing support for Gavi. 'To invoke misleading and inaccurate claims about vaccine safety as the pretext for cutting all global vaccine funding is cruel and reckless,' said Mihir Mankad, the charity's global health advocacy and policy director in the U.S. 'When we vaccinate in the community, parents line up for hours to give their children a chance to be protected from these deadly diseases. 'For these children, vaccination programs … are a matter of life and death.' Kennedy's recorded speech to Gavi came on the same day that his reconstituted U.S. vaccine advisory panel met for the first fired the previous 17-member panel this month and replaced it with a seven-member group that includes several vaccine skeptics.
